Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
CLINICAL_TRIALS approval · 2017-10-25Clinical Trial Update: Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Update notes that Olaparib is available via an expanded access program as maintenance therapy for ovarian, fallopian tube, or primary perito…
-
FDA approval · 2017-09-14FDA Approved: MVASI — Original Application (Amgen, Inc)
The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial comparing intraperitoneal versus intravenous chemotherapy after neoadjuvant treatment in ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients [Phase 2]
A Phase 2 trial evaluated the feasibility of performing interval debulking surgery via laparoscopy for chemosensitive peritoneal carcinomato…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
A pilot clinical trial update evaluating whether Chlamydia DNA can be detected by PCR in tissues from primary fallopian tube cancers and ova…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate in patients with persistent, recurrent, or refractorily advanced ovarian epithelial, fal…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer [NA]
Completed efficacy trial evaluating FloSeal for prevention of lymphocele after lymphadenectomy in gynecologic cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial results for GM-CSF (sargramostim) in women with recurrent ovarian cancer (including fallopian tube cancer) have been …
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer [Phase 1]
A Phase 1 trial of an ImmunoVaccine Technologies cancer vaccine for advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer has…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients [NA]
The University of Michigan completed a clinical trial evaluating guided imagery as a perioperative intervention in gynecologic oncology pati…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission [Phase 1]
A Phase 1 study of a unimolecular pentavalent immunization (Globo-H-GM2-sTn-TF-Tn) in patients with epithelial ovarian cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating whether intravenous glutathione can prevent paclitaxel/carboplatin-induced peripheral neuropathy…
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer [Phase 3]
Amgen's TRINOVA-3 Phase 3 trial evaluating AMG 386 with paclitaxel and carboplatin for ovarian, fallopian tube, and peritoneal cancers has b…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of lenalidomide with doxorubicin liposome in recurrent ovarian, fallopian tube, or primary peritoneal cancer; the s…